Tag: PostHumira

Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth?

AbbVie Inc. (NYSE:ABBV) recently released its first-quarter 2026 financial results, showcasing a robust performance with worldwide net revenues…